Zydus Lifesciences Limited informs Amplitude Surgical of undertakings by 7 shareholders to tender shares, reaching potential acquisition of over 90% capital and voting rights in Amplitude Surgical ...

Adtran Networks SE updates preliminary results for the financial year 2024, expecting a loss due to inventory adjustment. Full financial statements to be published on April 30, 2025 ...

NFL Biosciences annonce la mise à disposition de son rapport financier annuel 2024. Rapport comprenant gestion, gouvernance, comptes annuels et rapports des commissaires aux comptes ...

Publication mensuelle des informations sur le capital et les droits de vote au 31 mars 2025 selon les réglementations en vigueur ...

Gaumont dépose son Document d'enregistrement universel 2024 auprès de l'AMF, incluant rapport financier et gouvernance ...

Universal registration document with Autorité des Marchés Financiers. Available for public at registered office and online ...

Déclaration de franchissement de seuils de 5% du capital et des droits de vote de VALLOUREC par Boston Partners Global Investors pour le compte de leurs clients ...

Feuillet family concert to reclassify shares within the group, maintaining control over TRIGANO. Exemption from takeover bid requested from AMF ...

Cherry SE recognizes EUR 28.6 million asset impairment for fiscal year 2024 impacting adjusted EBITDA margin to -6.3% from -2.0% ...

NFL Biosciences presents its 2024 annual results and provides an update on its clinical program ...

Rubis annonce le franchissement du seuil statutaire de participation par Plantation des Terres Rouges S.A. avec 6,01% des actions et droits de vote ...

Leonteq publishes results of its Annual General Meeting 2025, including dividend increase to CHF 3.00 per share and rejected proposals. Enhanced capital requirements discussed ...